You are seeing Ask web results for prior treatment because there was not a match on Dictionary.com.
|
Low negative affect prior to treatment is associated with a decreased chance of live birth from a first IVF cycle. C. de Klerk1,5, J.A.M. Hunfeld1, ...
|
|
; Free Abstract Article (References) Article (PDF 147 KB) ; ... Lack of Effect of Prior Treatment with Fluoride on Genotoxicity of Two Chemical Agents in vitro; D.A. Ribeiroa, b, M.E.A. Marquesa, D.M.F. Salvadoria;
|
|
|
This was a retrospective multicenter study including 44 acute leukaemia patients who have received allogeneic haematopoietic SCT (allo-HSCT) after prior exposure to Gemtuzumab Ozogamicin (GO) + chemotherapy. Median interval between last administration of GO and allo-HSCT was 4.2 (range, 0.8–26.3) months.
|
|
|
Treatment of eight patients was stopped prior to completion of the planned four treatments due to presumed progression as defined by standard radiographic criteria (>25% increase in tumor size).
|
|
|
Background: Early heterogeneous virologic and immunologic response to HAART may relate to experience with antiretroviral therapies prior to the start of HAART and may affect subsequent clinical prognosis. Methods: ... Further follow-up will permit links with clinical outcomes and characterizations of treatment failures.
|
|
|
Quick Summary: Healthcare facilities which provide psychiatric care must seek out patients’ records of prior psychiatric care, and review the records to assess each patient’s risk of doing harm to self and others and of eloping from the treatment setting.
|
|
|
Response of serum inhibin B and pro-{alpha}C levels to gonadotrophic stimulation in normal men before and after steroidal contraceptive treatment; Hum. Reprod., ... N. Pitteloud, F. J. Hayes, P. A. Boepple, S. DeCruz, S. B. Seminara, D. T. MacLaughlin, and W. F. Crowley Jr. The Role of Prior Pubertal Development,
|
|
|
We report our experience of further endocrine response with another endocrine agent after prior fulvestrant treatment. ... Table 2 Response at 6 months (number of patients) to fulvestrant in patients who had received prior treatment with an aromatase inhibitor...
|
|
|
In both Phase III clinical studies, patients will receive 4 weeks of treatment with PEGINTRON and REBETOL prior to the addition of boceprevir. ... In the 48-week treatment arm, patients will receive PEGINTRON and REBETOL plus boceprevir for a total treatment duration ... Pivotal Study in Patients Who Failed Prior Treatment;
|
|
|
characteristics of admissions with many prior treatment episodes, SAMHSA, OAS ... Substance abuse treatment admissions reporting 5 or more prior treatment episodes were more likely than first time admissions to report opiates as their primary substance of abuse (36% vs. 10%).
|
